Literature DB >> 8500915

Purification and characterization of streptolysin O secreted by Streptococcus equisimilis (group C).

D Gerlach1, W Köhler, E Günther, K Mann.   

Abstract

Streptolysin O (SLO) was purified from culture supernatants of group C streptococci. The final product was either the complete, native molecule (SLOn [pI, 6.0]) with the N-terminal sequence (Asp)-Ser-Asn-Lys-Gln-Asn-Thr-Ala-Asn-Thr-Glu-Thr- or a large fragment (SLOf [pI, 7.3]) with the N-terminal sequence Ala-Pro-Lys-Glu-Met-Pro-Leu-Glu-Ser-Ala-Glu-Lys-Glu-Glu-Lys-.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8500915      PMCID： PMC280909          DOI： 10.1128/iai.61.6.2727-2731.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  28 in total

1.  Purification and characterization of streptolysin O from Streptococcus pyogenes.

Authors:  F Canalias; J Viver; J Beleta; F Gonzalez-Sastre; F Javier Gella
Journal:  Int J Biochem       Date:  1992-07

2.  The production, concentration, and partial characterization of streptolysin O.

Authors:  E I PENTZ; Y SHIGEMURA
Journal:  J Bacteriol       Date:  1955-02       Impact factor: 3.490

3.  Heterogeneity of hemolytic efficiency and isoelectric point of streptolysin O.

Authors:  J Suzuki; S Kobayashi; K Kagaya; Y Fukazawa
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

4.  A new method for predicting signal sequence cleavage sites.

Authors:  G von Heijne
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

5.  Physical separation of streptococcal nicotinamide adenine dinucleotide glycohydrolase from streptolysin O.

Authors:  S Shany; P S Grushoff; A W Bernheimer
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

6.  Isolation of streptolysin O by preparative polyacrylamide gel electrophoresis.

Authors:  D E Van Epps; B R Andersen
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

7.  The effect of the physico-chemical parameters of Streptococcus pyogenes cultures on the formation of O-streptolysin. II. The role of reducing agents in the formation of O-streptolysin.

Authors:  I Füvessy; J Böszörményi; A Veress
Journal:  Acta Microbiol Acad Sci Hung       Date:  1967

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Interaction of streptolysin-O with biomembranes: kinetic and morphological studies on erythrocyte membranes.

Authors:  W Niedermeyer
Journal:  Toxicon       Date:  1985       Impact factor: 3.033

Review 10.  Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin).

Authors:  J E Alouf
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310
View more
  4 in total

1.  Structural studies of Streptococcus pyogenes streptolysin O provide insights into the early steps of membrane penetration.

Authors:  Susanne C Feil; David B Ascher; Michael J Kuiper; Rodney K Tweten; Michael W Parker
Journal:  J Mol Biol       Date:  2013-12-03       Impact factor: 5.469

Review 2.  Single molecule fluorescence approaches shed light on intracellular RNAs.

Authors:  Sethuramasundaram Pitchiaya; Laurie A Heinicke; Thomas C Custer; Nils G Walter
Journal:  Chem Rev       Date:  2014-01-08       Impact factor: 60.622

3.  Different forms of streptolysin O produced by Streptococcus pyogenes and by Escherichia coli expressing recombinant toxin: cleavage by streptococcal cysteine protease.

Authors:  M Pinkney; V Kapur; J Smith; U Weller; M Palmer; M Glanville; M Messner; J M Musser; S Bhakdi; M A Kehoe
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

Review 4.  The MACPF/CDC family of pore-forming toxins.

Authors:  Carlos J Rosado; Stephanie Kondos; Tara E Bull; Michael J Kuiper; Ruby H P Law; Ashley M Buckle; Ilia Voskoboinik; Phillip I Bird; Joseph A Trapani; James C Whisstock; Michelle A Dunstone
Journal:  Cell Microbiol       Date:  2008-06-28       Impact factor: 3.715
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.